Literature DB >> 3619433

Methylation of demethylavermectins.

M D Schulman, C Ruby.   

Abstract

Demethylavermectins, which lack methyl groups on the oleandrose moiety, were fed to wild-type "Streptomyces avermitilis," which produces the normal avermectin components, and the bioconversion products were identified. The oleandrose units of the demethylavermectins were not methylated by the wild-type strain, but the C-5 of the macrolide ring was methylated. This demonstrates that methylation of the oleandrose units is not a terminal step in avermectin biosynthesis and that it occurs before attachment of the sugars to the macrolide ring. Avermectin biosynthesis thus differs from that of tylosin and erythromycin, in which methylation of the hexose moieties is a terminal reaction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3619433      PMCID: PMC284225          DOI: 10.1128/AAC.31.6.964

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  S-adenosylmethionine:erythromycin C O-methyltransferase.

Authors:  J W Corcoran
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Biosynthesis of the avermectins by Streptomyces avermitilis. Incorporation of labeled precursors.

Authors:  M D Schulman; D Valentino; O Hensens
Journal:  J Antibiot (Tokyo)       Date:  1986-04       Impact factor: 2.649

3.  Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties.

Authors:  T W Miller; L Chaiet; D J Cole; L J Cole; J E Flor; R T Goegelman; V P Gullo; H Joshua; A J Kempf; W R Krellwitz; R L Monaghan; R E Ormond; K E Wilson; G Albers-Schönberg; I Putter
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

4.  S-Adenosyl-L-methionine: macrocin O-methyltransferase activities in a series of Streptomyces fradiae mutants that produce different levels of the macrolide antibiotic tylosin.

Authors:  E T Seno; R H Baltz
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

5.  "Streptomyces avermitilis" mutants defective in methylation of avermectins.

Authors:  M D Schulman; D Valentino; S Streicher; C Ruby
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

6.  Avermectin B2 O-methyltransferase activity in "Streptomyces avermitilis" mutants that produce increased amounts of the avermectins.

Authors:  M D Schulman; D Valentino; M Nallin; L Kaplan
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

7.  Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component.

Authors:  J R Egerton; D A Ostlind; L S Blair; C H Eary; D Suhayda; S Cifelli; R F Riek; W C Campbell
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

8.  Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Authors:  R W Burg; B M Miller; E E Baker; J Birnbaum; S A Currie; R Hartman; Y L Kong; R L Monaghan; G Olson; I Putter; J B Tunac; H Wallick; E O Stapley; R Oiwa; S Omura
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

9.  Properties of S-adenosyl-L-methionine:macrocin O-methyltransferase in extracts of Streptomyces fradiae strains which produce normal or elevated levels of tylosin and in mutants blocked in specific O-methylations.

Authors:  E T Seno; R H Baltz
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

10.  Demethylavermectins. Biosynthesis, isolation and characterization.

Authors:  M D Schulman; D Valentino; O D Hensens; D Zink; M Nallin; L Kaplan; D A Ostlind
Journal:  J Antibiot (Tokyo)       Date:  1985-11       Impact factor: 2.649

  10 in total
  1 in total

1.  Deletion analysis of the avermectin biosynthetic genes of Streptomyces avermitilis by gene cluster displacement.

Authors:  T MacNeil; K M Gewain; D J MacNeil
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.